Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kawaishi, M. Hashimoto, H. Yanagisawa, T. Kazuyori, N. Takasaka, Y. Yumino, S. Fujii, J. Kojima, T. Ishikawa, T. Numata, H. Hara, K. Saito, J. Araya, K. Nakayama, K. Kuwano (Tokyo, Japan). Investigation of biomarkers for pulmonary carcinomatous lymphangitis in patients with lung cancer. Eur Respir J 2011; 38: Suppl. 55, 2801

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 The coexistance of active pulmonary tuberculosis in lung cancer patients Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Clinical profile of idiopathic pulmonary fibrosis with lung cancer Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 A case of lung cancer complicated with pulmonary thromboemboli Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 The coexistence of lung cancer and pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003 Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing Source: Eur Respir J 2004; 24: 502-505 Year: 2004 Some characteristics of empyema in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Systemic inflamation and bronchial dysplasia in risk lung cancer subjects Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016 Lung function in patients with benign asbestos related pleural disease Source: Eur Respir J 2003; 22: Suppl. 45, 185s Year: 2003 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021